Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Reliq Health Technologies Inc V.RHT

Alternate Symbol(s):  RQHTF

Reliq Health Technologies Inc. is a Canada-based global healthcare technology company that specializes in developing virtual care solutions. The Company's target markets include virtual care, long-term care and big data. iUGO Care, the Company's platform, is a software as a service solution that supports care coordination and community-based healthcare. The iUGO Care platform integrates... see more

TSXV:RHT - Post Discussion

Reliq Health Technologies Inc > RHT and VHI past CEO Lisa Crossely
View:
Post by AricanTwin on Feb 07, 2024 10:44am

RHT and VHI past CEO Lisa Crossely

When I decided to invest in this field I bought 2 and Lisa Crossely was CEO of both at one time. I purchased RHT on the belief that she seen a even better version of Vitalhub in Reliq. CTO are not unusual, but the length of time is unusual. My understanding our CTO is because of KPMG wanting boarding and off boarding policy documents ? Chris has stated on 1/1 with investors over the last week, No revenue changes on financials ? I believe 3 quarters of profit ? ......
Comment by lscfa on Feb 07, 2024 11:06am
If there are no revenue recognition changes then Jun qtr should be double Mar qtr due to large hardware sales....     Qtr ending Device sales SAAS rev  Total rev Jun 23 (e) 6,121,595 2,167,363 8,288,958 Mar ...more  
Comment by theinvestor22 on Feb 07, 2024 11:08am
He also said that the many bottlenecks have been cleared and that adherence is improving.  If all these statements are confirmed by actual results, then we're off to the races.  Of course, one has to actually receive that confirmation.  And so, we wait.. 
Comment by Mitch43 on Feb 07, 2024 11:53am
Ahem, what would be your reason to trust a poster with only 1 post on this board under his belt.?! Please enlighten us!.... if you can...
Comment by Mitch43 on Feb 07, 2024 11:54am
Ahem, what would be your reason to trust a poster with only 1 post on this board under his belt.?! Please enlighten us!.... if you can...
Comment by Mitch43 on Feb 07, 2024 11:48am
Ahem,  with an history of one post on this discussion board  you lack credibility in your post. discussing a 7 yr old event...and you got it wrong to begin with. Lisa Crossley's Vitalhub interest was purchased by the Thindal brothers and associates after they had acquired the controlling shares of Moseda technologies inc a small health CO in 2015- 2016  which they planned as a ...more  
Comment by mjh9413 on Feb 07, 2024 1:02pm
VHI was an in-house development at a hospital is my understanding and Crossley was simply 'associated' with it, like a backroom systems group. It took off (but we know it took many years of development) when she had nothing to do with it at all, certainly not in its public domain. Besides VHI's business model was not at all like RHTs RHT was formerly Moseda (sp?) when it had that " ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities